comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 09:29:57 - browse：897

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： He's a Nobel laureate. Critics say he was misleading on Covid

hotspot

entertainment

WSS

PBM reform efforts get punted in Congress

New documents shed light on MD Anderson Cancer Institute feud

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Obesity drugs seen as possible treatment for liver disease MASH

A solution to the after

Obesity drugs seen as possible treatment for liver disease MASH

explore

comprehensive

explore

Sports medicine is finally prioritizing gender equality

Zyn nicotine pouches become unlikely player in latest culture war

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

As demand for Covid shots wanes, Moderna seeks its next success

Reconstructing family trees of blood cells may help predict disease

State Dept. review finds Biden bears some blame for Afghanistan failures

NIH study of ME/CFS points to clear biological hallmarks

Peter Hotez and the public health issue of online harassment

Ed Silverman on new gene therapies, biosimilars, coffee, and more

entertainment

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Pancreatic cancer early detection could be helped by AI

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

A solution to the after

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

entertainment

hotspot

entertainment

focus